Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00112	Bevacizumab	0	Recruiting	1
DB13062	ME-344	0	Recruiting	1
DB05136	Bavituximab	1	Completed	1
DB08871	Eribulin	1	Recruiting	1
DB11793	Niraparib	1	Recruiting	1
DB01229	Paclitaxel	1	Completed	1
DB01229	Paclitaxel	1	Recruiting	1
DB13005	Rebastinib	1	Recruiting	1
DB00515	Cisplatin	1 / 2	Terminated	1
DB01590	Everolimus	1 / 2	Recruiting	1
DB00990	Exemestane	1 / 2	Recruiting	1
DB09073	Palbociclib	1 / 2	Recruiting	1
DB01217	Anastrozole	2	Recruiting	1
DB01217	Anastrozole	2	Terminated	1
DB00112	Bevacizumab	2	Recruiting	1
DB00531	Cyclophosphamide	2	Completed	1
DB00531	Cyclophosphamide	2	Recruiting	1
DB00997	Doxorubicin	2	Completed	1
DB00997	Doxorubicin	2	Recruiting	1
DB08871	Eribulin	2	Recruiting	2
DB00990	Exemestane	2	Recruiting	1
DB00947	Fulvestrant	2	Not Yet Recruiting	1
DB00947	Fulvestrant	2	Recruiting	1
DB01006	Letrozole	2	Not Yet Recruiting	1
DB01006	Letrozole	2	Recruiting	1
DB00331	Metformin	2	Completed	1
DB09073	Palbociclib	2	Not Yet Recruiting	1
DB09073	Palbociclib	2	Recruiting	2
DB06589	Pazopanib	2	Terminated	1
DB00675	Tamoxifen	2	Recruiting	1
DB00072	Trastuzumab	2	Completed	1
DB00997	Doxorubicin	3	Active Not Recruiting	1
DB01590	Everolimus	3	Recruiting	1
DB00990	Exemestane	3	Recruiting	1
DB00947	Fulvestrant	3	Recruiting	1
DB11793	Niraparib	3	Active Not Recruiting	1
DB09073	Palbociclib	Not Available	Completed	1